TSPO ligands have been shown to improve the pathological characteristics of diabetes, multiple sclerosis, Alzheimer’s disease, cancer, chronic pain and rheumatoid arthritis. Here, TSPO is linked to early-onset autosomal dominant Alzheimer disease.